AllPennyStocks.com TGTX Stock Pares Opening Losses After Analyst Dismisses Competition From Novartis
This section contains press releases and other materials from third parties (including paid content). AllPennyStocks.com has not reviewed this content. Please see our disclaimer.

TGTX Stock Pares Opening Losses After Analyst Dismisses Competition From Novartis

TGTX shares opened lower on Tuesday after Novartis said its drug remibrutinib improved multiple sclerosis in late-stage trials.

Other Penny Stock Movers

From Bitcoin to Big League Sports
Drill Hits 30% Hydrogen as Gas Reaches Surface
The First Ounces Out of a New Mine Are Almost Always Spoken For
Most Popular
{{ index + 1 }}


Back to Top